Sensodyne, the toothpaste first marketed in 1961 to reduce the pain of sensitive teeth, is among premium brands on sale in pharmacies and drug stores around the world. But if you live in an Indian ...

The global sarcopenia treatment market, valued at approximately USD 3.07 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.48% over the forecast period from 2024 to ...

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

JP Morgan reported in their recent outlook piece that "The backdrop for the European consumer is also improving. Real wages ...

Haleon PLC HLN shares slipped 1.03% to £3.63 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.66% to 8,938.32. Haleon ...

ABU DHABI, 15th July, 2025 (WAM) -- The UAE ranks first globally in health outreach programmes, community participation in health policy, and wellbeing promotion, according to the newly launched ...

“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...

Haleon PLC HLN shares slipped 1.08% to £3.67 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.15% to 8,867.02.

Haleon plc (NYSE:HLN) is one of the 15 successful spin-off companies. On July 4, the company broke ground on a new £130m Global Oral Health Innovation Center.

This week, Haleon, a global leader in consumer health and maker of leading brands such as Sensodyne, parodontax and Polident, broke ground on its new Global Oral Health Innovation Centre in ...